Peter Powchik, SVP Clin Devel & Reg Affairs at REGENERON PHARMACEUTICALS INC (REGN), sold 38,248 shares at $176.79 ($6.8M) on 2012-12-19, disclosed to the SEC on 2012-12-20.
Scheduled sale ($6.8M) by SVP Clin Devel & Reg Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $178.62 | 1,694 | $303K | 4.5% |
| 2 | $178.62 | 2,330 | $416K | 6.1% |
| 3 | $178.62 | 2,612 | $467K | 6.9% |
| 4 | $178.62 | 2,743 | $490K | 7.2% |
| 5 | $178.62 | 5,783 | $1.0M | 15.2% |
| 6 | $178.62 | 6,107 |
| $1.1M |
| 16.1% |
| 7 | $176.79 | 1,034 | $183K | 2.7% |
| 8 | $177.52 | 4,266 | $757K | 11.2% |
| 9 | $178.33 | 2,200 | $392K | 5.8% |
| 10 | $179.56 | 1,000 | $180K | 2.6% |
| 11 | $180.62 | 1,256 | $227K | 3.3% |
| 12 | $181.25 | 100 | $18K | 0.3% |
| 13 | $183.13 | 500 | $92K | 1.4% |
| 14 | $170.44 | 4,623 | $788K | 11.6% |
| 15 | $171.11 | 2,000 | $342K | 5.0% |
| Total | $177.21 avg | 38,248 | $6.8M | 100% |
| Filing → |
| REGN | SELL | 2014-01-03 | $5.7M | — | Filing → |
| REGN | SELL | 2013-12-20 | $2.5M | — | Filing → |
| REGN | SELL | 2013-12-17 | $2K | — | Filing → |